Oral Serotonin Receptor Agonists: A Review of Their Cost Effectiveness in Migraine

Author： Lofland Jennifer H.   Nash David B.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.3, 2005-01, pp. : 259-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin 5-HT Receptor Agonists in Migraine: Comparative Pharmacology and Its Therapeutic Implications

By Goadsby P.J.  

CNS Drugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 271-286

Adis International

Access to resources Recommend Favorite

Cost effectiveness of AEDs in migraine headache questioned

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Stratified Care in the Management of Migraine

By Williams P.  

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 819-829

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Facilitative Effect of Serotonin1A Receptor Agonists on Cognition in Patients with Schizophrenia

By  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 357-362

Bentham Science Publishers

Access to resources Recommend Favorite